CVS Health IR

The official Twitter channel for Investor Relations at $CVS Health Corporation (@CVSHealth). Sharing updates about our company and financial news. NYSE:CVS

[CVS Health IR @CVSHealthIR]

“Our focus on growth and operational execution persists and we continue to progress on our long-term strategy.” CFO Guertin $CVS https://t.co/K3sWL29dFV

[CVS Health IR @CVSHealthIR]

“…We anticipate continued strong cash flow from operations in 2022 and have raised our guidance accordingly to a range of $13.5 to $14.5 billion, with capital expenditures unchanged at a range of $2.8 to $3.0 billion.” CFO Guertin $CVS https://t.co/WGtoCoeHKT

[CVS Health IR @CVSHealthIR]

“Turning to our 2022 outlook, we are raising the mid-point of our adjusted earnings per share guidance by $0.10, to a range of $8.55 to $8.65.” CFO Guertin $CVS https://t.co/GkC6SvTdjb

[CVS Health IR @CVSHealthIR]

“During the quarter, we repaid $2.6 billion of long-term debt… We remain committed to maintaining our investment grade ratings while also having the flexibility to deploy capital strategically for capability-focused M&A.” CFO Guertin $CVS https://t.co/D6dPYOSrt5

[CVS Health IR @CVSHealthIR]

“Turning to the balance sheet, our liquidity and capital position remain excellent. YTD we generated cash flow from operations of $18.1 billion and ended the quarter with $7.9 billion of cash at the parent and unrestricted subsidiaries.” CFO Guertin $CVS https://t.co/kcZ4XEBcxr

[CVS Health IR @CVSHealthIR]

“Pharmacy prescription volume grew 1.8% YoY reflecting increased utilization. Excluding the impact of COVID, pharmacy prescription volume increased by 3.6% YoY.” CFO Guertin $CVS https://t.co/gEQIK5k1Cg

[CVS Health IR @CVSHealthIR]

“[In Retail/LTC] …revenue of $26.7 billion grew nearly 7%, reflecting increased prescription and front store volume, including the sale of COVID-19 over-the-counter test kits, as well as pharmacy drug mix and brand inflation.” CFO Guertin $CVS https://t.co/3B5RLjXtDb

[CVS Health IR @CVSHealthIR]

“Total pharmacy claims processed increased by 3.6% above prior year, and 4.5% when excluding COVID-19 vaccinations, primarily attributable to new business in 2022 and increased utilization.” CFO Guertin $CVS https://t.co/ruNmG9VIXT

[CVS Health IR @CVSHealthIR]

“[In Pharmacy Services] during the third quarter, revenue of over $43 billion increased by nearly 11% YoY...” CFO Guertin $CVS https://t.co/tkVfzRbjV6

[CVS Health IR @CVSHealthIR]

“Our Medical Benefit Ratio of 83.5% improved 230 basis points YoY, reflecting lower impact from COVID and medical cost trends that remain modestly favorable to our pricing assumptions.” CFO Guertin $CVS https://t.co/beXn3eDC4K

[CVS Health IR @CVSHealthIR]

“Underlying growth in our Commercial business also remains strong. We are excited about the prospects of our individual exchange business, which now includes 12 states as of January 1, 2023.” CFO Guertin $CVS https://t.co/DMTJYEQ2BE

[CVS Health IR @CVSHealthIR]

“Our Medicare franchise remains a strong growth opportunity for us, adding 75 thousand members sequentially across our portfolio of solutions for individuals and employers.” CFO Guertin $CVS https://t.co/PxGzBylEwA

[CVS Health IR @CVSHealthIR]

“[In Health Care Benefits] third quarter revenue of $22.5 billion increased by nearly 10% over the prior year quarter. Membership grew 2.5% YoY despite the divestiture of 283 thousand lives from Aetna International earlier this year.” CFO Guertin $CVS https://t.co/DeGgr6wZKb

[CVS Health IR @CVSHealthIR]

“Our ability to generate cash remains strong. Our cash flow from operations was $9.1 billion in the third quarter and $18.1 billion YTD.” CFO Guertin $CVS https://t.co/Kz0COO2OgA

[CVS Health IR @CVSHealthIR]

“We delivered adjusted operating income of $4.2 billion and adjusted EPS of $2.09, representing increases of 3.9% and 6.1% versus prior year, respectively.” CFO Guertin $CVS https://t.co/ttn6RVVjlL

[CVS Health IR @CVSHealthIR]

“This momentum allows us to again raise our 2022 adjusted EPS guidance to a range of $8.55 to $8.65 per share.” CFO Guertin $CVS https://t.co/14UmVlhVxl

[CVS Health IR @CVSHealthIR]

“Our third quarter results reflect the continuation of the strong performance observed in the first half of 2022 as we exceeded our expectations for revenue, cash flow generation and adjusted earnings per share.” CFO Guertin $CVS https://t.co/dA43LsUVUh

[CVS Health IR @CVSHealthIR]

“I want to take this opportunity to again thank CVS Health colleagues, especially those in Florida and Puerto Rico who’ve faced natural disasters. Our teams pulled together to ensure care continuity for customers & the communities we serve.” CEO Lynch $CVS https://t.co/aDXHMEpODl

[CVS Health IR @CVSHealthIR]

“…We are working to decrease disparities with our focus on women’s health... As part of our “Here for Her” initiative, we are launching new MinuteClinic Virtual Care services to support women’s health that will be available 24/7.” CEO Lynch $CVS https://t.co/jslX5tHDMk

[CVS Health IR @CVSHealthIR]

“…We recently launched a new functionality that drives more choice and convenience for patients filling prescriptions. Patients can expedite urgent prescriptions, have visibility into out-of-pocket costs, and track their order status...” CEO Lynch $CVS https://t.co/4xpwOLikh6